The Oncology Institute, Inc. TOI Patient services — Depreciation expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s patient services — depreciation expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s patient services — depreciation expense?
- The Oncology Institute, Inc. (TOI) reported patient services — depreciation expense of $737K in Q1 2026.
- How has The Oncology Institute, Inc.'s patient services — depreciation expense changed year-over-year?
- The Oncology Institute, Inc.'s patient services — depreciation expense decreased by 2.4% year-over-year, from $755K to $737K.
- What is the long-term trend for The Oncology Institute, Inc.'s patient services — depreciation expense?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s patient services — depreciation expense has grown at a 45.1% compound annual growth rate (CAGR), from $659K to $2.92M.
- What does patient services — depreciation expense mean?
- Represents the systematic allocation of the cost of tangible assets used in the delivery of patient care over their useful lives. This metric reflects the capital intensity of the oncology service segment and the ongoing investment in medical equipment and facility infrastructure.